JP2011519375A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011519375A5 JP2011519375A5 JP2011507449A JP2011507449A JP2011519375A5 JP 2011519375 A5 JP2011519375 A5 JP 2011519375A5 JP 2011507449 A JP2011507449 A JP 2011507449A JP 2011507449 A JP2011507449 A JP 2011507449A JP 2011519375 A5 JP2011519375 A5 JP 2011519375A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- tumor
- administered
- days
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 14
- 206010061309 Neoplasm progression Diseases 0.000 claims 4
- 230000005751 tumor progression Effects 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 208000003174 Brain Neoplasms Diseases 0.000 claims 2
- 208000032612 Glial tumor Diseases 0.000 claims 2
- 206010018338 Glioma Diseases 0.000 claims 2
- 206010003571 Astrocytoma Diseases 0.000 claims 1
- 206010014967 Ependymoma Diseases 0.000 claims 1
- 241000282412 Homo Species 0.000 claims 1
- 208000000172 Medulloblastoma Diseases 0.000 claims 1
- 201000010133 Oligodendroglioma Diseases 0.000 claims 1
- 208000005017 glioblastoma Diseases 0.000 claims 1
- 206010027191 meningioma Diseases 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4929208P | 2008-04-30 | 2008-04-30 | |
| US61/049,292 | 2008-04-30 | ||
| US9480608P | 2008-09-05 | 2008-09-05 | |
| US61/094,806 | 2008-09-05 | ||
| PCT/US2009/002645 WO2009134396A2 (en) | 2008-04-30 | 2009-04-30 | Methods of using corticotropin-releasing factor for the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011519375A JP2011519375A (ja) | 2011-07-07 |
| JP2011519375A5 true JP2011519375A5 (https=) | 2012-06-21 |
Family
ID=41119761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011507449A Pending JP2011519375A (ja) | 2008-04-30 | 2009-04-30 | 癌治療のためのコルチコトロピン放出因子の使用法 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20100113341A1 (https=) |
| EP (1) | EP2259793A2 (https=) |
| JP (1) | JP2011519375A (https=) |
| KR (1) | KR20110021820A (https=) |
| CN (1) | CN102036680A (https=) |
| AU (1) | AU2009241813A1 (https=) |
| CA (1) | CA2722426A1 (https=) |
| CO (1) | CO6300959A2 (https=) |
| CR (1) | CR11762A (https=) |
| EC (1) | ECSP10010631A (https=) |
| IL (1) | IL209005A0 (https=) |
| MX (1) | MX2010011882A (https=) |
| NI (1) | NI201000185A (https=) |
| NZ (1) | NZ588877A (https=) |
| RU (1) | RU2010148803A (https=) |
| WO (1) | WO2009134396A2 (https=) |
| ZA (1) | ZA201007729B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010057962A2 (en) * | 2008-11-19 | 2010-05-27 | Neutron Limited | Crf conjugates with extended half-lives |
| CA2766322A1 (en) * | 2009-06-24 | 2010-12-29 | Stephen Evans-Freke | Methods of using corticotropin-releasing factor for the treatment of cancer |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2852054A (en) * | 1956-11-23 | 1958-09-16 | Motley Murat Brunson | Container and closure therefor |
| US4312523A (en) * | 1979-10-29 | 1982-01-26 | Paco Packaging Incorporated | Label for container having pharmaceutical product therein |
| US4415558A (en) | 1981-06-08 | 1983-11-15 | The Salk Institute For Biological Studies | CRF And analogs |
| AU9054582A (en) | 1982-09-29 | 1984-04-24 | Lederis, K.P., Mac Cannell, K.L.:ichikawa, T:river, J.E. | Urotensin peptides |
| US4528189A (en) | 1983-02-03 | 1985-07-09 | The Salk Institute For Biological Studies | Urotensin peptides |
| US4489163A (en) * | 1983-04-14 | 1984-12-18 | The Salk Institute For Biological Studies | rCRF and analogs |
| US5391485A (en) * | 1985-08-06 | 1995-02-21 | Immunex Corporation | DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues |
| US4810643A (en) * | 1985-08-23 | 1989-03-07 | Kirin- Amgen Inc. | Production of pluripotent granulocyte colony-stimulating factor |
| JPS63500636A (ja) * | 1985-08-23 | 1988-03-10 | 麒麟麦酒株式会社 | 多分化能性顆粒球コロニー刺激因子をコードするｄｎａ |
| US5342940A (en) * | 1989-05-27 | 1994-08-30 | Sumitomo Pharmaceuticals Company, Limited | Polyethylene glycol derivatives, process for preparing the same |
| KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5229940A (en) * | 1992-01-29 | 1993-07-20 | Conoco Inc. | Method of extracting three dimensional information from a grid of two dimensional seismic data |
| US5360352A (en) * | 1992-12-24 | 1994-11-01 | The Whitaker Corporation | Wire retainer for current mode coupler |
| US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5780431A (en) * | 1996-09-20 | 1998-07-14 | Neurobiological Technologies, Inc. | Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form |
| US6319900B1 (en) * | 1999-09-21 | 2001-11-20 | The Regents Of The University Of California | Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| CN1361180A (zh) * | 2000-12-26 | 2002-07-31 | 上海博德基因开发有限公司 | 一种新的多肽——促肾上腺皮质激素释放因子8.8和编码这种多肽的多核苷酸 |
| CN1382700A (zh) * | 2001-04-26 | 2002-12-04 | 上海博德基因开发有限公司 | 一种多肽——促肾上腺皮质激素释放因子－12.87和编码这种多肽的多核苷酸 |
| CA2358177A1 (en) * | 2001-10-03 | 2003-04-03 | Ted Ramsay | Label for pharmaceutical prescriptions |
| WO2004100997A2 (en) * | 2003-05-12 | 2004-11-25 | Affymax, Inc. | Spacer moiety for poly(ethylene glycol) -modified peptides |
| MXPA06014021A (es) * | 2004-06-04 | 2007-02-08 | Pfizer Prod Inc | Procedimiento para tratar crecimiento celular anormal. |
| BRPI0513062A (pt) * | 2004-07-08 | 2008-04-22 | Aimsco Ltd | composição farmacêutica, método de estimular a produção de pomc em um paciente, usos de um peptìdeo de crf isolado e de um peptìdeo de pomc isolado, e, métodos de tratamento para uma doença, de produzir crf e de tratamento curativo, melhorador ou profilático de uma doença |
| JP2006036013A (ja) * | 2004-07-27 | 2006-02-09 | Yamaha Motor Co Ltd | 自動二輪車 |
| US7311205B2 (en) * | 2005-01-25 | 2007-12-25 | Target Brands, Inc. | Pharmacy bottle system including label |
| US20100203048A1 (en) * | 2008-04-30 | 2010-08-12 | Stephen Evans-Freke | Methods of using corticotropin-releasing factor for the use of the treatment of cancer |
-
2009
- 2009-04-30 RU RU2010148803/15A patent/RU2010148803A/ru not_active Application Discontinuation
- 2009-04-30 KR KR1020107026626A patent/KR20110021820A/ko not_active Withdrawn
- 2009-04-30 WO PCT/US2009/002645 patent/WO2009134396A2/en not_active Ceased
- 2009-04-30 US US12/433,652 patent/US20100113341A1/en not_active Abandoned
- 2009-04-30 JP JP2011507449A patent/JP2011519375A/ja active Pending
- 2009-04-30 EP EP09739199A patent/EP2259793A2/en not_active Withdrawn
- 2009-04-30 MX MX2010011882A patent/MX2010011882A/es not_active Application Discontinuation
- 2009-04-30 NZ NZ588877A patent/NZ588877A/xx not_active IP Right Cessation
- 2009-04-30 CN CN2009801188091A patent/CN102036680A/zh active Pending
- 2009-04-30 AU AU2009241813A patent/AU2009241813A1/en not_active Abandoned
- 2009-04-30 CA CA2722426A patent/CA2722426A1/en not_active Abandoned
-
2010
- 2010-10-27 CR CR11762A patent/CR11762A/es not_active Application Discontinuation
- 2010-10-28 IL IL209005A patent/IL209005A0/en unknown
- 2010-10-28 ZA ZA2010/07729A patent/ZA201007729B/en unknown
- 2010-10-28 NI NI201000185A patent/NI201000185A/es unknown
- 2010-11-23 CO CO10146559A patent/CO6300959A2/es not_active Application Discontinuation
- 2010-11-24 EC EC2010010631A patent/ECSP10010631A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG135192A1 (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| EA201270570A1 (ru) | Комбинированная терапия раковых заболеваний с помощью соединений-ингибиторов hsp90 | |
| EA201290078A1 (ru) | Гетероциклические соединения для ингибирования pask | |
| BR112012023021A2 (pt) | compostos de indazol e seus usos | |
| JP2011522896A5 (https=) | ||
| MX344476B (es) | Metodos de tratar trastornos pulmonares con formulaciones de amikacina liposomal. | |
| CL2014002935A1 (es) | Metodo para tratar un paciente humano con esclerosis multiple con laquinimod, en una dosis diaria de alrededor de 1,2mg; un aforma de dosificacion unitaria oral de 1,2 mg de laquinimod y un portador | |
| WO2010151755A3 (en) | TREATMENT OF INFLAMMATORY DISEASES USING miR-124 | |
| MX2011009709A (es) | Compuestos para el tratamiento de la inflamacion y del dolor. | |
| NZ700924A (en) | Dosage regimen for a pi-3 kinase inhibitor | |
| CY1111588T1 (el) | Υποκατεστημενα καρβοξαμιδια ως ανταγωνιστες μεταβολοτροπου υποδοχεα ομαδας ι | |
| RU2012108439A (ru) | Способы лечения опухолей головного мозга | |
| EP4302825A3 (en) | Pharmaceutical compositions for treatment of inappetence | |
| WO2007009720A3 (en) | Prodrugs of pyrazoline compounds, their preparation and use as medicaments | |
| MX2008011020A (es) | Compuestos de receptor sigma. | |
| TW200738699A (en) | 4-Substituted pyrazoline compounds, their preparation and use as medicaments | |
| RU2016137926A (ru) | Композиции грапипранта и способы их применения | |
| JP2011519375A5 (https=) | ||
| JP2015512948A5 (https=) | ||
| TN2010000120A1 (en) | Galenical formulations of organic compounds | |
| RU2009145804A (ru) | Аксомадол для лечения боли от артроза | |
| WO2015004634A3 (es) | Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio | |
| IN2015DN00735A (https=) | ||
| RU2008107113A (ru) | Средство и способ профилактики и лечения пациентов с болезнью альцгеймера | |
| MX2008011017A (es) | Compuestos de receptor sigma. |